Ras/ERK signalling in cannabinoid tolerance: From behaviour to cellular aspects

Journal of Neurochemistry

Volumn 93, Issue 4, 2005, Pages 984-991

  Rubino, Tiziana ^a   Forlani, Greta ^b   Viganò, Daniela ^a   Zippel, Renata ^b   Parolaro, Daniela ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

CB1 receptor plasticity in the CNS; Chronic 9 tetrahydrocannabinol treatment; Extracellular regulated kinase pathway; Hypolocomotion; Ras guanine nucleotide exchange factor 1 knock out mice; SL327

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR; DRONABINOL; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; RAS PROTEIN; SL 327; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR; BRAIN REGION; CAUDATE NUCLEUS; CEREBELLUM; CONTROLLED STUDY; DRUG TOLERANCE; ENZYME ACTIVATION; HIPPOCAMPUS; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; RECEPTOR DOWN REGULATION;

AMINOACETONITRILE; ANALGESICS; ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BRAIN; CYCLOHEXANOLS; DIAGNOSTIC IMAGING; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; PROTEASE INHIBITORS; PROTEIN BINDING; RAS-GRF1; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; SULFUR ISOTOPES; TETRAHYDROCANNABINOL; TRITIUM;

EID: 18844399321     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03101.x     Document Type: Article

References (26)

1. Atkins C. M., Selcher J. C., Petraitis J. J., Trzaskos J. M. and Sweatt J. D. (1998) The MAPK cascade is required for mammalian associative learning. Nat. Neurosci. 1, 602-609.
2. Bass C. E. and Martin B. R. (2000) Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice. Drug Alcohol Depend. 60, 113-119.
3. Brambilla R., Gnesutta N., Minichiello L. et al. ( 1997) A role for the Ras signalling pathway in synaptic transmission and long-term memory. Nature 390, 281-286.
4. Breivogel C. S., Childers S. R., Deadwyler S. A., Hampson R. E., Vogt L. J. and Sim-Selley L. J. (1999) Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J. Neurochem. 73, 2447-2459.
5. Derkinderen P., Valijent E., Toutant M., Corvol J. C., Enslen H., Leadent C., Trzaskos J., Caboche J. and Girault J. A. (2003) Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J. Neurosci. 23, 2371-2382.
6. Howlett A. C., Barth F., Bonner T. I. et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54, 161-202.
7. Innocenti M., Zippel R., Brambilla R. and Sturani E. (1999) CDC25 (Mm)/Ras-GRF1 regulates both Ras and Rac signaling pathways. FEBS Lett. 460, 357-362.
8. Lee M. C., Smith F. L., Stevens D. L. and Welch S. P. (2003) The role of several kinases in mice tolerant to delta 9-tetrahydrocannabinol. J. Pharmacol. Exp Ther. 305, 593-599.
9. Lefkowitz R. J. (1998) G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J. Biol. Chem. 273, 18 677-18 680.
10. Liu J. G. and Anand K. J. (2001) Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res. Brain Res. Rev. 38, 1-19.
11. Martin B. R., Sim-Selley L. J. and Selley D. E. (2004) Signaling pathways involved in the development of cannabinoid tolerance. Trends Pharmacol. Sci. 25, 325-330.
12. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C. and Bonner T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
13. Mattingly R. R. and Macara I. G. (1996) Phosphorylation-dependent activation of the Ras-GRF/CDC25Mm exchange factor by muscarinic receptors and G-protein beta gamma subunits. Nature 382, 268-272.
14. Munro S., Thomas K. L. and Abu-Shaar M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365, 61-65.
15. Oviedo A., Glowa J. and Herkenham M. (1993) Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Brain Res. 616, 293-302.
16. Romero J., Garcia L., Fernandez-Ruiz J. J., Cebeira M. and Ramos J. A. (1995) Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Pharmacol. Biochem. Behav. 51, 731-737.
17. Romero J., Garcia-Palomero E., Castro J. G., Garcia-Gil L., Ramos J. A. and Fernandez-Ruiz J. J. (1997) Effects of chronic exposure to delta-9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Brain Res. Mol Brain Res. 46, 100-108.
18. Rubino T., Vigano D., Massi P., Spinello M., Zagato E., Giagnoni G. and Parolaro D. (2000a) Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions. Neuropharmacology 39, 1331-1336.
19. Rubino T., Vigano D., Massi P. and Parolaro D. (2000b) Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940. J. Neurochem. 75, 2080-2086.
20. Rubino T., Vigano D., Costa B., Colleoni M. and Parolaro D. (2000c) Loss of cannabinoid-stimulated guanosine 5′-O-(3-[(35) S]Thio-triphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats. J. Neurochem. 75, 2478-2484.
21. Rubino T., Forlani G., Vigano D., Zippel R. and Parolaro D. (2004) Modulation of extracellular signal-regulated kinases cascade by chronic delta 9-tetrahydrocannabinol treatment. Mol Cell Neurosci. 25, 355-362.
22. Schmidt H., Schulz S., Klutzny M., Koch T., Handel M. and Hollt V. (2000) Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells. J. Neurochem. 74, 414-422.
23. Selcher J. C., Atkins C. M., Trzaskos J. M., Paylor R. and Sweatt J. D. (1999) A necessity for MAP kinase activation in mammalian spatial learning. Learn Mem. 6, 478-490.
24. 35S]GTPgammaS autoradiography in rat brain. J. Neurosci. 16, 8057-8066.
25. Tonini R., Franceschetti S., Parolaro D. et al. (2001) Involvement of CDC25Mm/Ras-GRF1-dependent signaling in the control of neuronal excitability. Mol Cell Neurosci. 18, 691-701.
26. Trincavelli M. L., Tuscano D., Marroni M., Klotz K. N., Lucacchini A. and Martini C. (2002) Involvement of mitogen protein kinase cascade in agonist-mediated human A (3) adenosine receptor regulation. Biochim. Biophys. Acta 1591, 55-62.